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Abstract  
Heat-killed (HK) Mycobacterium obuense is a novel immunomodulator, currently 
undergoing clinical evaluation as an immunotherapeutic agent in the treatment of cancer. 
Here, we examined the effect of in vitro exposure to HK M. obuense on the expression of 
different categories of surface receptors on human blood myeloid (m) and plasmacytoid 
(p) DCs. Moreover, we have characterized the cytokine and chemokine secretion patterns 
of purified total blood DCs stimulated with HK M. obuense. HK M. obuense significantly 
up-regulated the expression of CD11c, CD80, CD83, CD86, CD274 and MHC class II on 
whole blood mDCs and CD80, CD123 and MHC class II on whole blood pDCs. Down-
regulation of CD195 expression on both DC subpopulations was also noted. Further 
analysis showed that HK M. obuense up-regulated the expression of CD80, CD83 and 
MHC class II on purified blood DC subpopulations. TLR 2 and 1 were also identified to 
be engaged in mediating the HK M. obuense-induced upregulation of surface receptor 
expression on whole blood mDCs. In addition, our data demonstrated that HK M. 
obuense augmented the secretion of CCL4, CCL5, CCL22, CXCL8, IL-6, IL-12p40 and 
TNF-α by purified total blood DCs. Taken together, our data suggest that HK M. obuense 
exerts potent differential immunomodulatory effects on human DC subpopulations. 
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Introduction 
Dendritic cells (DCs) are crucial modulators of the immune response whereby 
they act as a bridge between the innate and adaptive immune systems.
1
 DCs are potent 
antigen presenting cells (APCs) that are in continuous surveillance for antigens while 
being in an immature state. Upon exposure to an antigen (self/foreign) or to a pro-
inflammatory stimulus, DCs undergo a maturation process and migrate towards 
secondary lymphoid organs where they interact with T cells, consequently inducing an 
antigen-specific immune response or initiating immune tolerance.
2,3
 The hallmarks of DC 
maturation include upregulation of co-stimulatory (CD80, CD86), antigen presentation 
(MHC class I and II) and maturation (CD83) receptors in addition to the release of pro-
inflammatory cytokines (IL-6, IL-12).
4,5
 To date, DCs are broadly categorized into two 
phenotypically and functionally distinct subpopulations defined as the conventional or 
myeloid (m) and plasmacytoid (p) DCs. Both subpopulations exist in peripheral blood 
and they comprise < 1% of peripheral blood mononuclear cells (PBMCs).
6,7
   
The vital requirement for an effective immunotherapeutic approach for the 
treatment of various diseases has resulted in the development of novel strategies which 
exploit the biological properties of DCs.
8,9
 DCs are equipped with a specialized set of 
receptors known as pattern recognition receptors (PRRs) which identify specific microbe 
or damage associated molecular patterns (MAMPs or DAMPs).
10
 Therefore, this unique 
and pivotal characteristic of DCs makes them a potential target for bacteria-based 
immunomodulatory agents which, upon binding to PRRs on DCs, trigger a chain of 
events that leads to transcriptional activation, alterations in DC’s cytokine/chemokine 
release, and a variation in surface receptor expression, thus affecting the interaction 
between DCs and other immune cells.
11,12
 Among the bacteria-based immunomodulators, 
heat killed (HK) Mycobacterium vaccae (M. vaccae) preparation has demonstrated 
immunotherapeutic and vaccine potentials when evaluated in different disease settings.
13-
17
 In recent years, there has been a growing interest in assessing additional HK 
mycobacterial preparations, as potential immunotherapeutic agents, particularly in 
cancer. HK M. obuense (NCTC13365) has been shown to be safe and well tolerated 
among stage III/IV melanoma patients.
18
 A recent randomized phase II study has 
demonstrated that the use of HK M. obuense as an adjunctive immunotherapeutic agent 
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for treating advanced pancreatic cancer was well tolerated and led to a significant 
extension in the overall and progression-free survival of patients with metastatic 
disease.
19
 Research into the mode of action of HK M. vaccae and M. obuense has 
demonstrated their abilities to directly affect the innate arm of the immune system. In a 
study in allergic mice, M. vaccae was reported to promote the development of CD11c
+
 
antigen presenting cells (APCs) demonstrating a possible regulatory role.
20
 Evidence 
from in vitro studies on human blood cells clearly indicated that both HK M. vaccae and 
M. obuense are able to modulate the expression of various cell surface receptors on 
monocytes and neutrophils
21
 and to stimulate cytokine release from type-1 mDCs thus 
leading to the enhancement of the anti-tumor activity of γδ T cells.22 Moreover, priming 
of monocyte-derived (Mo)-DCs with M. vaccae was reported to correlate with a 
significant attenuation of T helper type 2 (Th2) responses.
23
   
Despite the emerging clinical interest in HK M. obuense, little is known about the 
outcome of its interaction with human innate immune cells, particularly primary blood 
DCs. The purpose of our study was to analyze the effect of HK M. obuense stimulation 
on the expression of different categories of surface receptors on whole blood and purified 
blood DCs and to evaluate whether toll-like receptors (TLRs) are involved in the M. 
obuense-induced upregulation of surface receptor expression on whole blood mDCs. In 
addition, we examined the secretion of cytokines and chemokines by purified total blood 
DCs stimulated with HK M. obuense. Our results showed that HK M. obuense 
differentially regulates the expression of surface receptors related to antigen presentation, 
co-stimulation and maturation on blood DCs. Furthermore, our data revealed that TLR-2 
and TLR-1 contribute to the M. obuense-induced upregulation of CD11c, CD80 and 
MHC class II expression on whole blood mDCs. Finally, HK M. obuense demonstrated 
an ability to induce cytokine and chemokine production by purified total blood DCs.  
Materials and methods 
Blood Sampling 
Peripheral whole blood samples were drawn, at the clinical laboratory department, 
Nini, hospital, Lebanon, from healthy donors and collected into K2 ethylene diamine 
tetraacetic acid (K2-EDTA) vacutainer tubes (BD Biosciences). Written informed 
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consents were obtained from all blood donors and the study procedure gained approval 
from the institutional review board at the University of Balamand and from the research 
ethics committee at the Faculty of Science, Engineering and Computing at Kingston 
University. 
TLR blocking antibodies and reagents 
Anti-human monoclonal blocking antibodies against TLR-1 (clone H2G2), TLR-2 
(clone B4H2), TLR-4 (clone W7C11), TLR-5 (clone Q2G4), TLR-6 (clone C5C8) and 
matching isotype control mouse IgG1 (clone T8E5) and human IgA2 (clone T9C6) 
antibodies were purchased from Invivogen (Toulouse, France). Sterile vials of HK M. 
obuense (NCTC13365) suspended in borate-buffered saline (BBS; pH 8.0) at 50 mg/mL 
were manufactured by BioElpida (Lyon, France), whereby each 1 mg wet-weight of 
bacilli is roughly equivalent to 10
9
 HK organisms.  
Immunophenotyping of DCs 
Whole blood cultures (total culture volume = 2 mL) were either left unstimulated 
or were stimulated with 30, 100 or 300 μg/ml of HK M. obuense for 3 and 6 h at 37 °C in 
a 5% CO2 humidified atmosphere. For purified total blood DCs, viable cells were 
resuspended at 10
5
 cells/ml in complete RPMI 1640 medium (Lonza) supplemented with 
10% heat inactivated human AB serum and were stimulated with M. obuense for 6 h, as 
mentioned above. Whole blood cultures or purified blood DCs incubated with equivalent 
amounts of BBS served as unstimulated control. Both mDC and pDC subpopulations 
were analyzed in whole blood and as purified cells for the expression of a group of cell 
surface receptors. Whole blood (100 μl) was incubated for 25 min at room temperature 
(RT) in the dark with optimized concentrations of antigen-specific or matching isotype 
control monoclonal antibodies (Supplementary Table S1) and red blood cells were then 
lysed by the addition of FACS lysing solution (BD Biosciences). After 15 min of 
incubation at RT, cells were pelleted and washed once with Cell Wash solution (BD 
Biosciences) and finally resuspended in Cell Fix solution (BD Biosciences). For the 
immunophenotyping of purified blood DCs, a similar procedure was adopted; however, 
the incubation and centrifugation steps were carried out at 4 °C and an Fc receptor 
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blocking step with 10% heat inactivated human AB serum (Lonza, Slough, UK) was 
introduced (15 min incubation period) prior to incubating cells with antibodies. Fixed 
cells were run on a FACSCalibur flow cytometer (BD Biosciences) and the generated 
data was acquired and analyzed using Cell Quest Pro software (BD Biosciences). A total 
of 2.5-3 x 10
5
 leukocytes or 5 x 10
3
 purified total blood DCs were acquired per sample. 
Single-color stained controls were used to set compensation settings. Total blood 
dendritic cells (DCs) were identified as Lineage
-
/HLA-DR
+
, while blood mDCs and 
pDCs were identified as Lineage
-
/HLA-DR
+
/CD11c
+
/CD123
-
 and Lin
-
/HLA-
DR
+
/CD123
+
/CD11c
-
, respectively. The expression of each cell surface receptor was 
indicated as the percentage of cells positive or a particular surface receptor within a gated 
cell population or as the raw geometric mean fluorescence intensity (MFI) of the 
receptor-positive cell population.  
Isolation of CD4
+
 T cells and blood DCs 
PBMCs were isolated from peripheral blood using the standard Ficoll-Paque 
gradient method, as previously described.
21
 CD4
+
 T cells and total blood DCs were 
purified from PBMCs by negative selection using the Dynabeads untouched human CD4 
T cells and human DC enrichment kits, respectively, and following the manufacturer's 
instructions (Thermo Fisher Scientific, Waltham, MA, USA). For the depletion of 
platelets, biotin-conjugated mouse anti-human CD41 antibody (clone M148; Leinco 
Technologies, St. Louis, MO, USA) was added to the antibody cocktail present in the DC 
enrichment kit. Isolated cells were checked for purity by flow cytometry and were 
consistently found to be > 95% and ~ 80% for CD4
+
 T cells and DCs, respectively. Cells 
were routinely analyzed for viability with trypan blue exclusion method and showed > 
90% viability.  
Antigen presentation assay 
Freshly purified total blood DCs were seeded in a 96-well flat-bottom plate at a 
density of 1 x 10
4 
viable cells/well in complete RPMI medium supplemented with 10% 
heat inactivated human AB serum and were either left unstimulated or were stimulated 
with 300 μg/ml of HK M. obuense in the presence or absence of 10 µg/ml Candida 
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albicans (C. albicans) soluble antigen (Greer Laboratories, Lenoir, NC USA), for 7 days 
at 37 °C in a 5% CO2 humidified atmosphere. After 1 day in culture, DCs were co-
cultured with 1 x 10
5 
purified autologous CD4
+
 T cells to obtain a T-cell/DC ratio of 
10:1. Co-cultures were maintained for a period of 6 days at 37 °C in a 5% CO2 
humidified atmosphere. Cells were pulsed with 1 μCi/well tritiated thymidine (Perkin 
Elmer, San Jose, CA, USA) during the last 16 h of co-culture period. Cells were then 
harvested onto glass fiber filter disks (Connectorate AG, Dietikon, Switzerland) using a 
cell harvester (Inotech Biotechnologies, Basel, Switzerland). Proliferation of CD4
+
 T 
cells was assessed by measuring the radioactivity of incorporated methyl-tritiated-
thymidine in a liquid scintillation counter (PerkinElmer) and which was obtained as 
counts per minute (cpm). Unstimulated (containing equivalent amounts of BBS as 
vehicle) DCs co-cultured with CD4
+
 T cells as well as CD4
+
 T cells, without DCs, 
stimulated with HK M. obuense plus C. albicans served as negative controls. Stimulation 
index (SI) was calculated by dividing the mean cpm value of DC-CD4
+
 T cell co-cultures 
(triplicate) stimulated with HK M. obuense and/or C. albicans over the mean cpm value 
of unstimulated DC-CD4
+
 T cell co-cultures (triplicate).     
TLR blocking 
Whole blood was incubated with 10 μg/mL of cell culture grade, azide-free 
blocking monoclonal antibodies against TLR1, TLR2, TLR4, TLR5, TLR6 or isotype 
control antibodies (mentioned above) for 1 h prior to stimulating whole blood with 300 
μg/ml of HK M. obuense for 3 h. The efficiency of TLR blocking antibodies has been 
previously validated.
21
  
Detection of chemokine and cytokine production 
Purified total blood DCs (5 x 10
4
 cells/ml) were either left unstimulated or were 
stimulated with 300 μg/ml of HK M. obuense for 24 h at 37 °C in a 5% CO2 humidified 
atmosphere. DC culture supernatants were collected after 24 h and were stored at −20°C 
until further analysis. Levels of CCL4, CCL5, CCL22, CXCL8, IFN-α, IL-6, IL-10, IL-
12p40 and TNF-α were determined in DC culture supernatants using commercially 
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available sandwich enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, 
Abingdon, UK) and performed according to the manufacturer’s protocol. 
Statistical analysis  
Statistical analysis of the data was carried out using GraphPad Prism software 
(version 6; GraphPad Software, San Diego, CA, USA). Data are presented as mean 
values ± standard error of the mean (SEM). Statistical differences were determined by 
paired t-test, Wilcoxon matched-pairs signed rank test or one-way ANOVA test followed 
by the Dunn’s post-hoc test and were considered to be statistically significant at p-values 
< 0.05. 
Results 
HK M. obuense modulates the expression of different surface 
receptors on whole blood mDCs and pDCs  
Flow cytometric analysis of DC subpopulations in whole blood was done initially 
by gating viable leukocytes and excluding debris and dead cells on the basis of their 
FSC/SSC characteristics at 3-, 6- and 24-h time points. Within this gate, total DCs were 
recognized as Lineage
-
/HLA-DR
+
 and the mDC and pDC subpopulations were further 
defined in the gated DC population as Lineage
-
/HLA-DR
+
/CD11c
+
/CD123
-
 and Lineage
-
/HLA-DR
+
/CD123
+
/CD11c
-
, respectively (Figure 1a).  Preliminary experiments over a 3-
, 6- and 24-h time course indicated that blood DCs tend to lose their phenotype as 
Lineage
-
/HLA-DR
+ 
cells in 24-h unstimulated and M. obuense-stimulated whole blood 
cultures (Figure 1b). We performed a dose-response analysis to assess the effect of whole 
blood stimulation with HK M. obuense for 3 and 6 h on the surface expression of MHC 
class II on blood DCs. HK M. obuense upregulated the surface expression of MHC class 
II on blood DCs in a dose-dependent manner and this increase was apparently more 
prominent in mDCs than pDCs (Figure 1c). Based on these results, 300 g/ml of HK M. 
obuense was selected as an optimal concentration for regulating surface receptor 
expression in blood DCs and was employed in subsequent experiments. 
In order to determine whether in vitro whole blood stimulation with HK M. 
obuense would influence the phenotype of whole blood mDC and pDC subpopulations, 
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we measured the expression level of different categories of surface receptors on both DC 
subpopulations following a 3- and/or 6-h stimulation period. Representative flow 
cytometry figures of the percentage or MFI of receptor-positive mDCs are shown in 
Supplementary Figure S1. Among the antigen presentation receptors, only the MFI of 
MHC class II
+
 cells was significantly elevated (p < 0.05) on mDCs with a 1.75- and ~2.5-
fold change at 3 and 6 h after stimulation with HK M.obuense, respectively (Figure 2). 
mDCs responded to stimulation with HK M. obuense by significantly upregulating (p < 
0.05) the expression of the B7 family receptors where the percentages of CD80
+
 and 
CD86
+ 
mDCs were significantly increased 7- and 2-fold, respectively, after 3 h of 
stimulation as well as 38- and 2.5-fold, respectively, after 6 h of stimulation. However, a 
significant increase in the MFIs of CD80
+ 
and CD86
+ 
mDCs was noted only after 6 h of 
mycobacterial stimulation (Figure 2). The percentage and MFI of CD274
+ 
mDCs were 
significantly induced (p < 0.05) after 3 h of stimulation and these were even more evident 
at the 6-h time point (Figure 2). The expression of complement receptors was 
significantly enhanced on mDCs following stimulation with HK M. obuense. A 
significant upregulation (p < 0.05) in the percentage of CD11b
+ 
mDCs and in the MFI of 
CD11c
+ 
mDCs was observed at 3 h and at both incubation time points after M. obuense 
stimulation, respectively (Figure 2). Analysis of the expression of cytokine and 
chemokine receptors revealed that in response to HK M. obuense stimulation, the MFI of 
CD116
+
 mDCs and the percentage of CD253
+
 mDCs were significantly upregulated (p < 
0.05) at 3 and 6 h, respectively (Figure 2). On the other hand, the expression of CD195 
was significantly (p < 0.05) downregulated on mDCs at 3 and 6 h. Members of the PRRs 
demonstrated an enhanced expression on mDCs after stimulation with HK M. obuense. 
The percentages of CD282
+
 and CD284
+
 mDCs were significantly enhanced at both 
stimulation time points, whereas only the percentage of CD206
+
 mDCs and the MFI of 
CD282
+
 mDCs were significantly enhanced at the 3-h time point (Figure 2). Whole blood 
stimulation with HK M. obuense for 3 and 6 h also resulted in a marked increase (p < 
0.05) in the expression of the DC maturation marker, CD83, on mDCs (Figure 2).   
In response to whole blood stimulation with HK M. obuense, pDCs exhibited a 
modest but statistically significant regulation in the expression of a restricted number of 
receptors belonging to the antigen presentation, B7 family and cytokine and chemokine 
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families of receptors, while no significant regulation in the expression of the studied 
complement receptor and PRR families was detected (Figure 3). A mild but significant (p 
< 0.05) increase in the MFI of MHC class II
+ 
pDCs was observed after stimulation with 
HK M. obuense for 3 and 6 h (Figure 3). The percentage of CD80
+
 pDCs was slightly but 
significantly (p < 0.05) upregulated at 6 h after stimulation with HK M. obuense (Figure 
3). Moreover, 3- and 6-h M. obuense-stimulated pDCs demonstrated a slight but 
significant increase in the MFI of CD123
+
 cells and a significant decrease in the 
percentage and MFI of CD195
+ 
cells as compared to unstimulated pDCs (Figure 3). We 
could not detect any spontaneous or HK M. obuense-induced expression of CD1d, CD83 
CD91, CD282, CD284, and CD274 on pDCs (Figure 3).  
Additional receptors (CD40, CD197, CD209, CD273, CD275, and CD276) were 
also studied on both DC subpopulations and under similar conditions; however, their 
expression was neither constitutively expressed nor induced following mycobacterial 
stimulation. Taken together, our data reveal that whole blood stimulation with HK M. 
obuense resulted in significant variations in the expression of receptors on mDC and pDC 
subpopulations; however, these variations were more prominent on mDCs. Based on the 
significant upregulated expression of CD80, CD83, CD86 and MHC class II and 
downregulated expression of CD195 on M. obuense-stimulated mDCs, it can be inferred 
that HK M. obuense might drive mDCs towards acquiring a mature DC phenotype. 
TLR-2 and TLR-1 blocking reduces the HK M. obuense-induced 
upregulation of CD11c, CD80 and MHC class II expression on 
whole blood mDCs  
We have previously reported that TLR-2 and TLR-1 contribute to the M. obuense-
induced upregulation of surface receptor expression of CD11c and MHC class II on 
monocytes in whole blood.
21
 We therefore attempted to determine whether TLR-2 and 
TLR-1 in addition to other TLRs (TLR-4, 5 and 6) are also involved in mediating the M. 
obuense-induced expression of surface receptors on whole blood mDCs. TLR blocking 
experiments were carried out using specific blocking antibodies against TLR-1, 2, 4, 5 
and 6 whereby the effect of TLR blocking on the M. obuense-induced expression of 
selected receptors was studied. The selected receptors included: CD11c, CD80 and MHC 
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class II which represented three categories of surface receptors that demonstrated 
significant variations in expression (% or MFI) on mDCs following whole blood 
stimulation with HK M. obuense (Figure 2). Both single and simultaneous blocking of 
TLR-2 and TLR-1 led to a significant reduction (p < 0.05) in the M. obuense-induced 
expression of CD80 (% of CD80
+
 cells) and MHC class II (MFI of MHC class II
+
 cells) 
on mDCs, whereas blocking of TLR-2 and TLR-2/1 resulted in a significant reduction (p 
< 0.05) in the M. obuense-induced expression of CD11c (MFI of CD11c
+
 cells) on mDCs 
(Figure 4). We did observe a trend of an enhanced blocking effect with combined TLR-
2/1 blocking versus separate TLR blocking; however, this effect achieved statistical 
significance (p < 0.05) only against single TLR-2 blocking in the case of MHC class II. 
Although there was a trend towards a decrease in the M. obuense-induced expression of 
CD11c and MHC class II in response to TLR-1 and TLR-2/6 blocking, respectively, this 
decrease did not attain statistical significance (Figure 4). Simultaneous blocking of TLR-
2 and TLR-6 significantly reversed the M. obuense-induced expression of CD11c and 
CD80, an effect comparable to that observed with blocking TLR-2 alone (Figure 4). 
Blocking of TLR-4, 5 and 6 resulted in no significant reduction in the M. obuense-
induced upregulation of the three surface receptors (Figure 4).  
HK M. obuense modulates surface expression of different 
receptors on purified blood DCs 
Our results have shown that whole blood stimulation with HK M. obuense 
induced significant variations in the expression of different surface receptors on mDCs 
and pDCs in whole blood. This finding has prompted us to investigate whether the 
detected variations in receptor expression were merely related to a direct stimulatory 
effect induced by HK M. obuense on DCs or due to an indirect stimulatory effect induced 
by the whole blood milieu (other blood cells, pro-inflammatory cytokines, etc.). To 
answer this question, we examined the effect of stimulating purified blood DCs with HK 
M. obuense on the expression of different receptors that were selected to represent those 
which showed significant variations on whole blood DCs upon stimulation with HK M. 
obuense. Following 6 h stimulation with HK M. obuense, purified blood mDC and pDC 
subpopulations significantly upregulated (p < 0.05) the MFI of MHC class II
+
 cells 
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(Figure 5). A significant (p < 0.05) ~8.5- and 16.5-fold increase in the percentage of 
CD80
+
 cells was observed on M. obuense-stimulated purified blood mDCs and pDCs, 
respectively; however, only M. obuense-stimulated purified blood pDCs showed a 
significant 2.8-fold increase in the MFI of CD80
+
 cells (Figure 5). Unlike pDCs, M. 
obuense-stimulated purified blood mDCs revealed a significant elevation in the 
expression of CD274
+
 cells. M. obuense-stimulated purified blood mDCs and pDCs 
demonstrated, respectively, a significant upregulation (p < 0.05) in the percentage of 
CD253
+
 cells and in the MFI of CD123
+
 cells (Figure 5). Both mDCs and pDCs 
enhanced the percentage of CD83
+
 cells in response to stimulation with HK M. obuense. 
HK M. obuense induces cytokine and chemokine secretion by 
purified total blood DCs 
We next examined the cytokine and chemokine secretion patterns of purified total 
blood DCs stimulated with HK M. obuense. Stimulation of DCs with HK M. obuense for 
24 h was shown to substantially induce the release of CCL22 (1248 ± 324 pg/ml) and 
CXCL8 (2703 ± 443 pg/ml) (Figure 6). Moreover, M. obuense-stimulated DCs exhibited 
a significant (p < 0.05) ~18- and ~2-fold increase in the production of CCL4 and CCL5, 
respectively, as compared to unstimulated DCs (Figure 6). Stimulation with HK M. 
obuense also resulted in a weak, but significant (p < 0.05) secretion of IL-6, IL-12p40 
and TNF-α by DCs (Figure 6). On the other hand, levels of IFN-α and IL-10 were not 
detected in supernatants of either unstimulated or M. obuense-stimulated DC cultures. 
Effect of DC stimulation with HK M. obuense and/or C. albicans 
on CD4
+
 T-cell antigen-specific responses   
We investigated the ability of purified total blood DCs to present HK M. obuense 
antigens and/or C. albicans soluble antigen to autologous purified CD4
+
 T cells. DCs 
stimulated with HK M. obuense or C. albicans induced comparable autologous CD4
+
 T-
cell proliferation with SIs of 24 ± 14 and 25 ± 14, respectively. However, concomitant 
stimulation of DCs with HK M. obuense and C. albicans antigens elicited significantly (p 
< 0.05) higher CD4
+
 T-cell proliferative responses (SI = 51± 26) than DCs stimulated 
separately with HK M. obuense or with C. albicans alone (Supplementary Figure S2). 
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Further analysis of our CD4
+
 T-cell proliferation data clearly demonstrated that the 
autologous CD4
+
 T-cell proliferative responses induced by DCs stimulated with HK M. 
obuense and C. albicans were not statistically different (p > 0.05) from the additive 
proliferative responses to each antigen separately. As expected, low CD4
+
 T cell 
proliferation was noted when these lymphocytes were stimulated with both antigens, but 
without the presence of DCs (280 ± 66 cpm), or when co-cultured with DCs, but without 
the presence of antigens (504 ± 107 cpm).  
Discussion 
Shedding light on the outcome of interaction of an immunomodulator with 
immune cells is a vital step towards understanding the immunomodulator’s mode of 
action. Over the past few years, HK M. obuense, a novel systemic immunomodulator, has 
attracted the attention of cancer researchers;
18,19
 however, little is known about the 
consequences of its interaction with human innate immune cells. In this study we 
investigated the effect of HK M. obuense on the phenotype and cytokine/chemokine 
secretion profile of human blood DCs, which are limited in number,
24
 and represent a 
challenge in the study of human DC biology. To the best of our knowledge, this is the 
first study to describe the effect of HK M. obuense on human whole blood and purified 
primary blood DCs.  
Our first approach was aimed at examining the effect of in vitro exposure to HK 
M. obuense on the expression of a group of receptors belonging to six different categories 
on mDC and pDC subpopulations in a human whole blood model which represents a 
physiologically relevant system that has been used extensively to assess the effect of 
several immunomodulators on the phenotype, function and responses of blood DCs.
25-27
 
During initial time-course studies, we could not identify DCs either in unstimulated or in 
M. obuense-stimulated 24 h whole blood cultures due to the loss of their unique flow 
cytometric profile as Lineage
-
/HLA-DR
+
 cells. A previous study has also failed to 
measure intracellular cytokine production by human DC subpopulations in 24 h-whole 
blood cultures due to an inability to reliably detect different DC subpopulations.
28
 On the 
contrary, other studies have reported the detection of human DC subpopulations after 20-
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24 h culture period of whole blood and were able to assess DC’s phenotype and 
function.
27,29
 The reasons behind this discrepancy with our data are not clear. 
In response to whole blood stimulation with HK M. obuense, mDCs demonstrated 
a considerable increase in the expression of CD11c, CD80, CD83, CD86, CD274, CD282 
(TLR-2), CD284 (TLR-4) and MHC class II with a concomitant decrease in the 
expression of CD195 (CCR5). On the other hand, pDCs showed a slight but significant 
increase in the expression of CD80 and MHC class II and a decrease in the expression of 
CD195. Based on the screened battery of surface receptors on mDCs, it was evident that 
whole blood stimulation with HK M. obuense favored the upregulation of a specific set of 
receptors (CD80, CD83, CD86, MHC class II) which are signature receptors correlating 
with the maturation status of DCs.
30
 Similar induction of phenotypic maturation receptors 
has been reported on human Mo-DCs, phenotypically identical to mDCs,
31
 by some 
mycobacterial species such as live or HK M. bovis, HK M. vaccae, and live, HK or γ-
irradiated M. tuberculosis,
23,32-36
 but not by HK M. leprae.
34
 Moreover, our data showed a 
significant downregulation of CD195 (CCR5) expression on M. obuense-stimulated 
whole blood mDCs and pDCs. A similar rapid downregulation of CCR5 surface 
expression has been previously noted on Mo-DCs that are undergoing maturation.
37
 
Furthermore, HK M. obuense showed an ability to upregulate the expression of CD274 
(PDL-1) on whole blood mDCs, a phenomenon which has been observed following 
stimulation of Mo-DCs with whole cell lysates of M. tuberculosis.
38
  
The critical role of TLRs in mediating the recognition and response to 
mycobacterial antigens in innate immune cells has been emphasized in several studies. 
TLR-2 (as a heterodimer with either TLR-1 or TLR-6), TLR-4 and TLR-9 have been 
demonstrated to be engaged in sensing various mycobacterial cell wall components such 
as glyoclipids, glycoproteins, diacylated and triacylated lipoproteins, heat-shock proteins 
as well as unmethylated CpG motifs in mycobacterial DNA.
39,40
 An earlier study from 
our group has suggested a role for TLR-2 and TLR-1 in mediating HK M. obuense-
induced upregulation of CD11c and HLA-DR expression on monocytes in whole blood 
culture system.
21
 The data presented here indicated that the M. obuense-induced 
upregulation of CD11c, CD80 and MHC class II expression on whole blood mDCs was 
mediated, at least in part, through the interaction of HK M. obuense with both TLR-2 and 
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TLR-1. Using a panel of HEK293 cells expressing different human TLRs, previous 
studies have shown that cellular activation of HEK293 cells by HK M. vaccae or HK M. 
indicus pranii was mediated through interaction with TLR-2 alone, with TLR-2/TLR-6 
heterodimer and more potently with TLR-2/TLR-1 heterodimer.
23,41
 Our data also point 
to a putative interaction between HK M. obuense and surface TLR-2/TLR-1 and which 
could be mediated by interaction with triacylated lipoproteins, known to constitute part of 
the mycobacterial cell wall components.
42-44
 Moreover, mycobacterial triacylated 
lipoproteins have been reported to activate and to promote the maturation of human Mo-
DCs.
45,46
  
In this study, we also examined the effect of stimulating purified blood DCs with 
HK M. obuense for 6 h on the expression of surface receptors on purified mDC and pDC 
subpopulations. Similar to the observed effects on whole blood DCs, M. obuense 
stimulation of purified blood DCs induced a significant upregulation in the expression of 
CD80 and MHC class II on both subpopulations of DCs and of CD83 and CD253 only on 
mDCs. Unlike whole blood pDCs, purified blood pDCs expressed low but detectable 
levels of CD83 and CD274 and upregulated CD83 expression upon stimulation with HK 
M. obuense. Furthermore, in contrast to whole blood mDCs, purified blood mDCs 
displayed no significant change in the expression of CD11c upon stimulation with HK M. 
obuense. These observed variations in M. obuense-induced surface receptor expression 
between whole blood and purified blood DCs might be a consequence of the DC 
enrichment process which eliminated other immune cells with potential contribution to 
the immunomodulatory effects of HK M. obuense on DCs. The differential regulation in 
expression of surface receptors between the two major DC subpopulations might be 
attributed to variations in the expression pattern of TLRs thus leading to differential 
recognition of HK M. obuense by mDCs and pDCs. Findings from this study as well as 
from previous studies have clearly indicated that human blood mDCs express TLR-2 
while blood pDCs lack TLR-2 expression.
47,48
 Therefore, the absence of surface TLR-2 
on pDCs might explain the differential regulation in surface receptors between mDCs and 
pDCs in response to whole blood stimulation with HK M. obuense. Despite the lack of 
TLR-2 surface expression on blood pDCs, the involvement of other receptor(s) such as 
Dectin-2,
49
 and nucleotide-binding oligomerization domain-containing protein 2 
 
 
16 
 
(NOD2)
50,51
 in mediating the above mentioned effects of HK M. obuense on blood pDCs 
should not be neglected. A putative role for human blood mDC-pDC cross-talk in 
mediating the observed pDCs responses to HK M. obuense, despite the absence of TLR-2 
expression, should be also taken into consideration. This mDC-pDC cross-talk has been 
reported to reverse the absence of responsiveness of purified human blood pDCs to 
recombinant bacillus Calmette-Guerin (rBCG) infection when cultured alone, but to 
allow the upregulation of MHC class I, II, CD86 and CD123 expression when co-
cultured with rBCG-infected mDCs.
52-54
 
Cytokines and chemokines produced by DCs are critically essential in developing 
subsequent immune responses.
55,56
 In this study, we found that purified total blood DCs 
stimulated with HK M. obuense mostly exhibited increased levels of secretion of several 
proinflammatory cytokines and chemokines including IL-6, IL-12p40, TNF-α, CCL4, 
CCL5 and CXCL8. Our observation is in accordance with a previous report whereby 
treating Mo-DCs with HK BCG or HK M. bovis for 24 h stimulated their production of 
CCL5 and TNF-α.57 Given our data showing that TLR-1 and TLR-2 are involved in 
mediating DC responses to HK M. obuense, a previous study has also demonstrated the 
ability of the specific TLR1/2 ligand, Pam3CSK4, to enhance the production of CXCL8, 
IL-6 and TNF-α by purified total blood DCs.58 IFN-α, a cytokine reported to be mainly 
released in high amounts by pDCs upon activation of their TLRs,
59
 was not detectable in 
supernatants from both unstimulated and M. obuense-stimulated purified total blood DC 
cultures. This observation may suggest a lack of pDC’s cytokine response to stimulation 
with HK M. obuense. 
Our finding that HK M. obuense induces DC phenotypic changes consistent with 
a mature-like phenotype suggests that priming purified blood DCs with HK M. obuense 
might also result in an enhanced ability of DCs to present antigens and to activate T-cells. 
Mo-DCs primed with HK M. vaccae have been shown to enhance autologous CD4
+
 T-
cell responses to the recall antigen tetanus toxoid.
23
 To address this hypothesis, we 
attempted to study the effect of priming purified blood DCs with HK M. obuense on the 
autologous CD4
+
 T cell proliferative responses to the soluble recall antigen, C. albicans; 
however, our attempt was unsuccessful due to the following technical difficulties. First, 
the number of purified blood DCs from 50 ml of peripheral blood was low and not 
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achieving > 5 x 10
5
 cells. This prohibited the ability of performing adequate bulk DC 
priming and comparing with unprimed DCs due to cell loss upon centrifugation and 
washing. Second, the continued presence of HK M. obuense organisms with DCs even 
after bulk stimulation, centrifugation and washing. Third, the continued presence of HK 
M. obuense organisms in wells of cultured DCs (1 x 10
4 
cells/well) due to an inability to 
carry out vigorous washing dictated by the non-adherent nature of the purified blood 
DCs. Despite the above-mentioned limitations, we assessed the ability of purified blood 
DCs to present mycobacterial antigens and/or C. albicans antigen to autologous CD4
+
 T 
cells. We noted significant proliferation of the CD4
+
 T cells that were induced by M. 
obuense-stimulated DCs. This is in line with our previous report where we observed 
strong PBMC proliferative responses against HK M. obuense in healthy non-BCG-
vaccinated individuals in Lebanon.
21
 Our results also suggest no interference between the 
mycobacterial antigens and C. albicans antigen presentation mechanisms as evidenced by 
the additive CD4
+
 T cell responses induced by purified blood DCs simultaneously 
stimulated with HK M. obuense and C. albicans.    
Collectively our data provide a new insight into the outcome of interaction 
between HK M. obuense and human DCs and uncover the immunomodulatory effects of 
this mycobacterial preparation on DCs. Our findings might have significant implications 
in the design of immunotherapy protocols that could exploit the immunomodulatory 
properties of HK M. obuense to augment DC-mediated immune responses. 
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Figure 1. (a) Gating scheme for identification of myeloid (m) and plasmacytoid (p) 
dendritic cells (DCs) in whole blood. Viable leukocytes were gated based on forward and 
side scatter (FSC and SSC) properties. Among the gated leukocyte population, DCs were 
identified as Lineage
-
/HLA-DR
+ 
and within this DC population, mDC and pDC 
subpopulations were identified as Lineage
-
/HLA-DR
+
/CD11c
+
/CD123
-
 and Lineage
-
/HLA-DR
+
/CD123
+
/CD11c
-
, respectively. (b) Loss of flow cytometric profile of total 
DCs (Lineage
-
/HLA-DR
+
) in 24 h whole blood cultures. Total DCs were identified in 
whole blood cultures that were either left unstimulated or were stimulated with 300 μg/ml 
of heat killed (HK) M. obuense for 3, 6 and 24 h. Flow cytometry graphs are 
representative of three independent experiments. (c) Dose-response assessment for the 
effect of whole blood stimulation with HK M. obuense for 3 and 6 h on the expression 
level of MHC class II on mDCs and pDCs. Whole blood was stimulated with various 
concentrations of HK M. obuense (30, 100 and 300 μg/ml) for 3 and 6 h and the 
expression level of MHC class II, presented as geometric mean fluorescence intensity 
(MFI) of MHC class II
+
 DCs, was measured on mDC and pDC subpopulations. Symbols 
and error bars indicate mean values and SEM, respectively (n=4). Statistically significant 
differences were determined by one-way ANOVA test followed by the Dunn’s post-hoc 
test (*p < 0.05 versus unstimulated). 
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Figure 2. Whole blood stimulation with heat-killed (HK) M. obuense modulates surface 
expression of different receptors on myeloid (m) dendritic cells (DCs). Whole blood 
cultures were either left unstimulated or were stimulated with 300 μg/ml of HK M. 
obuense for 3 and 6 h and the expression level of different categories of cell surface 
receptors was measured on mDCs. Column bars represent mean values of the percentage 
(%) and geometric mean fluorescence intensity (MFI) of receptor-positive mDCs of at 
least 3 donors. Error bars represent SEM. Statistically significant differences were 
determined by paired t-test (*p < 0.05 versus unstimulated). NT: not tested. 
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Figure 3. Whole blood stimulation with heat-killed (HK) M. obuense modulates surface 
expression of different receptors on plasmacytoid (p) dendritic cells (DCs). Whole blood 
cultures were either left unstimulated or were stimulated with 300 μg/ml of HK M. 
obuense for 3 and 6 h and the expression level of different categories of cell surface 
receptors was measured on pDCs. Column bars represent mean values of the percentage 
(%) and geometric mean fluorescence intensity (MFI) of receptor-positive pDCs of at 
least 3 donors. Error bars represent SEM. Statistically significant differences were 
determined by paired t-test (*p < 0.05 versus unstimulated). NT: not tested. 
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Figure 4. Blocking of toll-like receptor (TLR)-2 and/or TLR-1 reduces the M. obuense-
induced upregulation of CD11c, CD80 and MHC class II expression on myeloid (m) 
dendritic cells (DCs) in whole blood. Whole blood cultures were pre-incubated with anti 
(α)-TLR-1, α-TLR-2, α-TLR-1/2, α-TLR6, α-TLR-2/6, α-TLR-4, α-TLR-5 or isotype-
matched control antibodies: IgA (for α-TLR-2 and 5) or IgG (for α-TLR-1, 4 and 6) for 1 
h and then stimulated with 300 μg/ml of heat-killed (HK) M. obuense (Mob) for 3 h 
followed by the analysis of the expression level of CD11c, CD80 and MHC class II on 
mDCs. Column bars represent mean values of the percentage (%) of CD80
+
 mDCs or the 
geometric mean fluorescence intensity (MFI) of CD11c
+
 and MHC class II
+
 mDCs of 3 
donors. Error bars represent SEM. Statistically significant differences were determined 
by Wilcoxon matched-pairs signed rank test (*p < 0.05 versus Mob). 
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Figure 5. Heat-killed (HK) M. obuense modulates surface expression of different 
receptors on purified dendritic cells (DCs). Purified total blood DCs were either left 
unstimulated or were stimulated with 300 μg/ml of HK M. obuense for 6 h and the 
expression level of different categories of cell surface receptors was measured on the 
mDC and pDC subpopulations. Column bars represent mean values of the percentage (%) 
and geometric mean fluorescence intensity (MFI) of receptor-positive mDCs and pDCs 
of 5 donors. Error bars represent SEM. Statistically significant differences were 
determined by paired t-test (*p < 0.05 versus unstimulated). 
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Figure 6. Heat-killed (HK) M. obuense induces the secretion of cytokines and 
chemokines by purified dendritic cells (DCs). Purified total blood DCs were either left 
unstimulated or were stimulated with 300 μg/ml of HK M. obuense for 24 h. Levels of 
CCL4, CCL5, CCL22, CXCL8, IFN-α, IL-6, IL-10, IL-12p40 and TNF-α were measured 
in DC culture supernatants. Column bars represent mean values of cytokine or chemokine 
concentration in DC culture supernatants of 7 donors. Error bars represent SEM. 
Statistically significant differences were determined by paired t-test (*p < 0.05 versus 
unstimulated).  
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Supplementary Table S1. List of antigen-specific and isotype control antibodies used 
for immunophenotyping of DCs 
Antigen-Specific 
Antibody 
Name Clone Conjugate Manufacturer 
CD1a T6/Leu-6 HI149 APC  
 
 
 
 
 
 
 
 
 
 
BD 
Biosciences 
CD1d R3G1 CD1d42 PE 
CD4 T-cell 
surface 
glycoprotein 
RPA-T4 PE 
CD11b CR3 ICRF44 PE 
CD11c CR4 B-ly6 APC 
CD32 FcγRII FLI8.26 APC 
CD40 TNFRSF5 5C3 APC 
CD80 B7-1 L307.4 PE 
CD83 HB15 HB15e APC 
CD86 B7-2 2331 APC 
CD91 HSPR A2MR-α2 PE 
CD116 GM-CSFRα hGMCSFR-M1 PE 
CD123 IL23R 9F5 PE 
CD184 CXCR4 12G5 APC 
CD195 CCR5 2D7/CCR5 APC 
CD197 CCR7 3D12 
Alexa Fluor-
647 
CD205 DEC-205 MG38 PE 
CD206 MMR 19.2 PE 
CD209 DC-SIGN DCN46 APC 
CD253 TRAIL RIK-2 PE 
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CD273 B7-DC/PD-
L2 
MIH18 APC 
CD274 B7H1/PD-L1 MIH1 PE 
CD275 B7H2 2D3/B7-H2 PE 
CD276 B7-H3 185504 APC 
R & D 
Systems 
CD282 TLR-2 TL2.1 PE 
eBioscience 
CD284 TLR-4 HTA125 PE 
HLA-ABC MHC I G46-2.6 PE 
BD 
Biosciences 
Lin 1 antibody 
cocktail:  CD3; 
CD14; CD16; 
CD19; CD20; 
CD56 
Lineage 1 
SK7; MφP9; 
3G8; SJ25C1; 
L27; 
NCAM16.2 
FITC 
HLA-DR MHC II L243 PerCP 
Isotype Control 
Antibody 
Name Clone Conjugate Manufacturer 
Mouse IgG1 NA MOPC-21 PE 
BD 
Biosciences 
 
Mouse IgG1 NA MOPC-21 APC 
Mouse IgG2a NA X39 PerCP 
Mouse IgG2a NA G155-178 APC 
Mouse IgG2b NA clone 27-35 PE 
Mouse IgG2b NA 27-35 APC 
Rat IgG2a NA R35-95 Alexa Fluor-
647 
Mouse IgG1 NA 11711 APC 
R & D 
Systems 
Mouse IgG2a NA eBM2a PE eBioscience 
 NA: not applicable 
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Supplementary Figure S1. Whole blood stimulation with heat killed (HK) M. obuense 
modulates surface expression of various receptors on myeloid (m) dendritic cells (DCs). 
Representative flow  cytometry graphs demonstrating the expression of CD11c, MHC 
class II (presented as histogram plots), CD80, CD83, CD195 and CD284 (presented as 
dot plots) on whole blood mDCs that were left unstimulated or stimulated with 300 g/ml 
of HK M. obuense for 3 and 6 h. Numbers in histogram plots correspond to the geometric 
mean fluorescence intensity (MFI) of receptor-positive mDCs in each condition (black 
line histogram: isotype control; green line histogram: unstimulated; red line histogram: 
M. obuense). Numbers within lower right quadrant of dot plots indicate the percentage of 
receptor-positive mDCs out of the total mDC population. SSC-H: side scatter height.  
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Supplementary Figure S2. Effect of stimulating DCs with heat-killed (HK) M. obuense 
and/or C. albicans on CD4
+
 T cell antigen- specific responses. Purified total blood 
dendritic cells (DCs) were either left unstimulated or were stimulated with 300 μg/ml of 
HK M. obuense and/or 10 μg/ml of the soluble recall antigen C. albicans for 7 days. After 
1 day in culture, DCs were co-cultured with autologous CD4
+
 T cells at a T cell/DC ratio 
of 10:1 for 6 days. Tritiated-thymidine incorporation, expressed as counts per minute 
(cpm), was measured after 6 days of co-culture. Unstimulated DCs co-cultured with 
CD4
+
 T cells as well as CD4
+
 T cells, without DCs, stimulated with HK M. obuense and 
C. albicans served as negative controls. Stimulation index (SI) was calculated by dividing 
the mean cpm value of DC-CD4
+
 T cell co-cultures stimulated with HK M. obuense 
and/or C. albicans over the mean cpm value of unstimulated DC-CD4
+
 T cell co-cultures. 
Column bars represent mean SI of 6 donors. Error bars represent SEM. Statistically 
significant differences were determined by Wilcoxon matched-pairs signed rank test (*p 
< 0.05).  
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